Abstract
Deficiency in homologous recombination repair (HRR) capacity is frequently observed in breast tumors. However, whether HRR deficiency is a tumor-specific biomarker or a risk factor for breast cancer is unknown. In this two-stage study, using a host cell reactivation assay, we assessed the relationship between HRR capacity in peripheral blood lymphocytes (PBLs) and breast cancer risk. The discovery stage included 152 breast cancer patients and 152 healthy controls matched on age and race. HRR capacity was found to be significantly lower in Black women than in White women among controls (P = 0.015) and cases (P = 0.012). Among cases, triple negative breast cancer patients had significantly lower HRR capacity than ER+/PR+ breast cancer patients (P = 0.006). In risk assessment, HRR capacity was found to be significantly lower in cases than in controls (P < 0.001), and decreased HRR capacity was associated with 1.42-fold increased risk of breast cancer (95% CI: 1.21, 2.53). In the validation stage, we assessed HRR capacity in a nested case-control study using pre-diagnostic samples. We found that decreased HRR capacity was associated with 1.21-fold increased risk of breast cancer (95% CI: 1.04, 4.58). In summary, our results demonst...Continue Reading
References
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
Jan 20, 2005·Journal of the National Cancer Institute·David O KennedyRegina M Santella
Jul 21, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jie LinXifeng Wu
Mar 8, 2007·Carcinogenesis·Luo WangMargaret R Spitz
Mar 17, 2007·DNA Repair·Thomas HelledayBevin P Engelward
Jun 24, 2010·BMC Biotechnology·Katharina BurgerJörg Bergemann
May 7, 2011·DNA Repair·Pedro MendezRafael Rosell
Oct 8, 2014·Nature Reviews. Clinical Oncology·Amir SonnenblickMartine Piccart
Apr 3, 2015·Cold Spring Harbor Perspectives in Biology·Rohit PrakashMaria Jasin
Apr 15, 2015·Cancer Medicine·Maren K LevinJoyce O'Shaughnessy
Apr 1, 2016·PloS One·Jaime MattaErick Suárez
Oct 8, 2016·Breast Cancer Research : BCR·Andrew D SkolKenan Onel
Jun 22, 2017·PLoS Genetics·Masahito KawazuHiroyuki Mano
May 8, 2018·Breast Cancer Research and Treatment·M L TelliE P Winer
Feb 5, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R CondorelliN C Turner
Feb 6, 2019·Breast Cancer : Targets and Therapy·Sumadee De SilvaEric Hamilton Karunanayake
Mar 18, 2019·Cancer Epidemiology·Jie ShenHua Zhao
Jul 12, 2019·Scientific Reports·Jie ShenHua Zhao
Aug 21, 2019·NPJ Breast Cancer·Anqi LiJorge S Reis-Filho